AnovaOS Network Powered Patient Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

NCT06014541

Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

ACTIVE_NOT_RECRUITING

Neurogenetics Patient Registry

NCT02995538

Neurogenetic Disorders

RECRUITING

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

NCT06092346

AMPD3, OMIM*102772, AMP Deaminase Deficiency AK1, OMIM *103000, Adenylate Kinase Deficiency AMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency +25 more

RECRUITING

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

NCT02450851

Genetic Disease

RECRUITING

Observational Study of Advanced Data Analytics in Genetic Conditions

NCT05657405

Genetic Conditions

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The AnovaOS™ Network Powered Patient Registry may be used to inform the development and conduct of clinical trials and observational studies designed to better understand, prevent, diagnose, treat, ameliorate or cure disease. The AnovaOS™ Network Powered Patient Registry may additionally be used to expedite identification and recruitment of participants for clinical trials of promising therapeutics and observational studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infectious Disease Neoplasms Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) Endocrine, Nutritional and Metabolic Diseases (E00-E89) Mental and Behavioural Disorders Diseases of the Nervous System Diseases of the Eye and Adnexa Diseases of the Ear and Mastoid Process Diseases of the Circulatory System Diseases of the Respiratory System Diseases of the Digestive System Diseases of the Skin and Subcutaneous Tissue Diseases of the Musculoskeletal System and Connective Tissue Diseases of the Genitourinary System Pregnancy, Childbirth and the Puerperium Certain Conditions Originating in the Perinatal Period Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99) Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified Injury, Poisoning and Certain Other Consequences of External Causes External Causes of Morbidity and Mortality Factors Influencing Health Status and Contact With Health Services

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old or older;
* Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
* Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
* Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
* Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
* Anticipated additional follow up with the registry once per year.

* Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes